231 related articles for article (PubMed ID: 26842600)
1. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
[TBL] [Abstract][Full Text] [Related]
2. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
3. Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.
Tsvetkov PO; Cheglakov IB; Ovsepyan AA; Mediannikov OY; Morozov AO; Telegin GB; Kozin SA
J Alzheimers Dis; 2015; 46(4):849-53. PubMed ID: 26402624
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
Zhu H; Wang X; Wallack M; Li H; Carreras I; Dedeoglu A; Hur JY; Zheng H; Li H; Fine R; Mwamburi M; Sun X; Kowall N; Stern RA; Qiu WQ
Mol Psychiatry; 2015 Feb; 20(2):252-62. PubMed ID: 24614496
[TBL] [Abstract][Full Text] [Related]
5. Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis.
Kozin SA; Cheglakov IB; Ovsepyan AA; Telegin GB; Tsvetkov PO; Lisitsa AV; Makarov AA
Neurotox Res; 2013 Oct; 24(3):370-6. PubMed ID: 23670398
[TBL] [Abstract][Full Text] [Related]
6. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
8. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
[TBL] [Abstract][Full Text] [Related]
9. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
Devi L; Ohno M
Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
[TBL] [Abstract][Full Text] [Related]
10. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
12. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
[TBL] [Abstract][Full Text] [Related]
13. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
[TBL] [Abstract][Full Text] [Related]
14. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
[TBL] [Abstract][Full Text] [Related]
15. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
[TBL] [Abstract][Full Text] [Related]
16. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
[TBL] [Abstract][Full Text] [Related]
17. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
18. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
[TBL] [Abstract][Full Text] [Related]
19. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
Kane MD; Lipinski WJ; Callahan MJ; Bian F; Durham RA; Schwarz RD; Roher AE; Walker LC
J Neurosci; 2000 May; 20(10):3606-11. PubMed ID: 10804202
[TBL] [Abstract][Full Text] [Related]
20. Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.
Gureviciene I; Gurevicius K; Mugantseva E; Kislin M; Khiroug L; Tanila H
J Alzheimers Dis; 2017; 55(1):147-157. PubMed ID: 27636846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
